doi:https://doi.org/

Journal: Evidence-based Cardiology. 2012;(4): 27‑31

Read: 2987 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

. Evidence-based Cardiology. 2012;(4):27‑31. (In Russ.)

Использование инфографики авторами научных работ

References:

Grodstein F., Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995;38:199-210.
Grodstein F., Stampfer M.J. Estrogen for women at varying risk of coronary disease. Maturitas 1998;30:19-26.
Grodstein F., Stampfer M.J., Manson J.E., et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996;335:453-461.
Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
Dubey R.K., Imthurn B., Barton M., Jackson E.K. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res 2005;66:295-306.
Hodis H.N., Mack W.J. A "window of opportunity": the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent. Brain Res 2011;1379:244-252.
Salpeter S.R., Walsh J.M., Greyber E., Salpeter E.E. Brief report: coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J Gen Intern Med 2006;21:363-366.
Salpeter S.R., Walsh J.M., Greyber E., et al. Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med 2004;19:791-804.
Mosekilde L., Beck-Nielsen H., Sorensen O.H., et al. Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas 2000;36:181-193.
Jensen L.B., Vestergaard P., Hermann A.P., et al. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res 2003;18:333-342.
Moyer V.A.; on behalf of the U.S. Preventive Services Task Force Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2012 Oct 23. doi: 10.7326/0003-4819-158-1-201301010-00553. Available at: www.annals.org/journal.aspx.
Nainggolan L. Debate reignites on HRT for chronic disease prevention. Available at: www.theheart.org/article/1461641.do.